These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29581802)

  • 21. Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project.
    Fenton D; Choi NK; Garcia NM; Dyer EC; Cohen NA; Rubin DT
    Crohns Colitis 360; 2022 Oct; 4(4):otac042. PubMed ID: 36778515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
    Jensen MD; Kjeldsen J; Nathan T
    Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations.
    Laserna-Mendieta EJ; Lucendo AJ
    Clin Chem Lab Med; 2019 Aug; 57(9):1295-1307. PubMed ID: 30785706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
    Kato J; Hiraoka S; Nakarai A; Takashima S; Inokuchi T; Ichinose M
    Intest Res; 2016 Jan; 14(1):5-14. PubMed ID: 26884729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal Calprotectin as a Useful Non-Invasive Screening Marker for Eosinophilic Gastrointestinal Disorder in Korean Children.
    Yoo IH; Cho JM; Joo JY; Yang HR
    J Korean Med Sci; 2020 May; 35(17):e120. PubMed ID: 32356420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    Zollner A; Schmiderer A; Reider SJ; Oberhuber G; Pfister A; Texler B; Watschinger C; Koch R; Effenberger M; Raine T; Tilg H; Moschen AR
    J Crohns Colitis; 2021 Jan; 15(1):43-54. PubMed ID: 32556317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reference Intervals for Fecal Calprotectin in Adults Using Two Different Extraction Methods in the Uppsala-SCAPIS Cohort.
    Fall T; Mandic-Havelka A; Helmersson-Karlqvist J; Sundstrom J; Larsson A
    Clin Lab; 2017 Sep; 63(9):1493-1496. PubMed ID: 28879709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis.
    Hiraoka S; Inokuchi T; Nakarai A; Takashima S; Takei D; Sugihara Y; Takahara M; Harada K; Okada H; Kato J
    Gut Liver; 2018 Mar; 12(2):142-148. PubMed ID: 28873508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.
    Nilsen T; Sunde K; Hansson LO; Havelka AM; Larsson A
    J Clin Lab Anal; 2017 Jul; 31(4):. PubMed ID: 27629827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach.
    Viola A; Fontana A; Belvedere A; Scoglio R; Costantino G; Sitibondo A; Muscianisi M; Inferrera S; Bruno LM; Alibrandi A; Trifirò G; Fries W
    Scand J Gastroenterol; 2020 Oct; 55(10):1176-1184. PubMed ID: 32838582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis.
    Goll R; Heitmann R; Moe ØK; Carlsen K; Florholmen J
    PLoS One; 2019; 14(12):e0224895. PubMed ID: 31790426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
    Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a fluorescent immunochromatography test for fecal calprotectin.
    Li R; Zhao X; Dong J; Zhu D; Wang T; Yang S; Zhao Z; Xiao N
    J Clin Lab Anal; 2020 Feb; 34(2):e23059. PubMed ID: 31587371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
    Gacesa R; Vich Vila A; Collij V; Mujagic Z; Kurilshikov A; Voskuil MD; Festen EAM; Wijmenga C; Jonkers DMAE; Dijkstra G; Fu J; Zhernakova A; Imhann F; Weersma RK
    Gut Microbes; 2021; 13(1):1943288. PubMed ID: 34313538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
    Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.